EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistent lymphocytopenia in convalescent patients with COVID-19: dysregulated B cell, CD4+ T cell, and treg compartments in 7–12% of moderate-severe cases

Hui An, Tongtong Yu, Anlan Wang, Hao Hu, Chen Zhang, Yongyu Wang, Ming Li

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1693743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Hui An und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: COVID-19, Lymphopenia, B-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long COVID manifests with heterogeneous clinical outcomes, potentially linked to immune dysfunction. However, the recovery of immune-cell subsets during convalescence remains incompletely understood.

Methods

In this longitudinal cohort, 279 unvaccinated patients with confirmed SARS-CoV-2 infection (13 mild, 218 moderate, 48 severe) were enrolled. Peripheral lymphocyte subsets were analyzed by flow cytometry at admission and at 50 days post-symptom onset (DPSO 50).

Results

Total T-cell counts normalized in 90–98% of patients in the moderate and severe groups by DPSO 50. Nevertheless, a subgroup exhibited persistent B-cell lymphopenia (<90 cells/µL) in 7.3% of moderate cases (median 77.1 cells/µL, IQR 51.9–83.8) and 12.5% of seltvere cases (median 54.5 cells/µL, IQR 28.4–79.3). Patients with B-cell deficiency also showed concurrent reductions in total T cells, CD4 + T cells, and CD4 + CD25 + CD127low/FOXP3 + regulatory T cells (Tregs). In moderate cases, CD4 + T cell and Treg counts correlated positively (r = 0.72, p < 0.001), independent of B-cell status, whereas this relationship was absent in severe cases, indicating severity-dependent immune dysregulation.

Conclusions

Approximately 7–12% of moderate-to-severe COVID-19 survivors displayed persistent lymphopenia affecting B cells, CD4 + T cells, and Tregs at ~50 days post-symptom onset. These findings highlight distinct recovery trajectories and provide insights into Long COVID pathogenesis that may inform therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19LymphopeniaB-LymphocytesCD4-Positive T-LymphocytesT-Lymphocytes, RegulatoryHumansMaleFemaleMiddle AgedLongitudinal StudiesConvalescenceSARS-CoV-2AdultAgedLymphocyte CountSeverity of Illness Index

Stichwörter der Autor:innen

B cellsCOVID-19T cellsconvalescent patientspersistent lymphocytopeniaregulatory T cells

Autor:innen und Institutionen

  • School of Basic Medical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Zitieren

APA

An, H., Yu, T., Wang, A., Hu, H., Zhang, C., Wang, Y., & Li, M. (2025). Persistent lymphocytopenia in convalescent patients with COVID-19: dysregulated B cell, CD4+ T cell, and treg compartments in 7–12% of moderate-severe cases. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1693743

Vancouver

An H, Yu T, Wang A, Hu H, Zhang C, Wang Y, et al. Persistent lymphocytopenia in convalescent patients with COVID-19: dysregulated B cell, CD4+ T cell, and treg compartments in 7–12% of moderate-severe cases. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1693743

BibTeX
@article{An2025,
  author = {An, Hui and Yu, Tongtong and Wang, Anlan and Hu, Hao and Zhang, Chen and Wang, Yongyu and Li, Ming},
  title = {Persistent lymphocytopenia in convalescent patients with COVID-19: dysregulated B cell, CD4+ T cell, and treg compartments in 7–12% of moderate-severe cases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1693743}
}
Kostenlos starten →